Pericarditis
[대역어] 심장막염
[용어속성] Term
[용어속성] Term
Acute Pericarditis Due to SARS-COV-2 in a Kidney Transplant Recipient
Cardiology
[키워드] acute respiratory syndrome
Atypical
Autoimmune disease
Care
contagious
coronavirus
COVID 19
etiology
highlight
increasingly
kidney transplant recipient
management
Manifestations
patient’s medical history
Pericarditis
presenting
recipient
Remdesivir
renal
Respiratory complications
SARS-CoV-2
the disease
therapy
Transplant
treated
treatment regimen
viral pericarditis
[DOI] 10.7759/cureus.16547 PMC 바로가기 [Article Type] Cardiology
[DOI] 10.7759/cureus.16547 PMC 바로가기 [Article Type] Cardiology
Myocarditis With COVID-19 mRNA Vaccines
Review
[키워드] COVID-19
COVID-19 vaccines
mRNA vaccine
myocarditis
Pericarditis
SARS-CoV-2
vaccination
[DOI] 10.1161/CIRCULATIONAHA.121.056135 PMC 바로가기 [Article Type] Review
[DOI] 10.1161/CIRCULATIONAHA.121.056135 PMC 바로가기 [Article Type] Review
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
Review
[키워드] acute respiratory syndrome
Analysis
cardiac
cardiac complication
chest pain
children
clinically
coronavirus
Corticosteroids
COVID-19
COVID-19 mRNA Vaccination
COVID-19 vaccination
COVID-19 vaccine
cross-sectional
elevated
immune
Infection
Inflammation
intravenous
magnetic resonance imaging
Mild
Most patient
mRNA
Myocardial
myocarditis
Myopericarditis
non-steroidal anti-inflammatory drug
Patient
Pericarditis
risk
SARS-CoV-2
second dose
symptomatic
treated
vaccine administration
[DOI] 10.3390/children8070607 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/children8070607 PMC 바로가기 [Article Type] Review
T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study
T2 매핑 증가는 활성 COVID-19에서 심근 관련의 일반적인 이미징 바이오마커입니다: 심혈관 자기 공명 연구
Observational Study
Published on
Journal: Journal of Cardiovascular Magnetic Resonance [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제,
Journal: Journal of Cardiovascular Magnetic Resonance [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제,
[키워드] Abnormalities
abnormality
active phase
Artery
Biomarker
cardiovascular
Cardiovascular Magnetic Resonance
change
characterization
clinical
Cohort
collected
Comparisons
control group
Coronary arteries
coronavirus disease
Coronavirus disease 2019
correlation
COVID-19
COVID-19 diagnosis
COVID-19 patients
cTnT
decrease
Diagnosis
disease
Early detection
edematous
enrolled
Evidence
evidence of
Extracellular
fraction
gadolinium
healthy control
healthy controls
in vivo
individual
individuals
Infection
Inflammation
IQR
Laboratory
laboratory characteristics
laboratory findings
linear correlation
median
moderate
Myocardial
myocardial damage
Myocardial infarction
myocardial injury
myocardial involvement
myocarditis
Observational cohort study
Occurrence
parameters
Patient
patients
Pericarditis
positive linear correlation
positively correlated
predominant
prevalent
protocol
Quantitative imaging
referred to
relationship
resonance
Result
retrospective
risk
risk factor
SARS-CoV-2
selected
sensitivity
Sex
supplementary material
Symptomatic treatment
time interval
tissue
troponin
troponin T
Volume
volume fraction
[DOI] 10.1186/s12968-021-00764-x PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s12968-021-00764-x PMC 바로가기 [Article Type] Observational Study
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
Cardiology
[키워드] Biomarker
CAD
Cardiomyopathy
cardiovascular
Case series
case sery
changes
Chest
chest pain
clinically suspected
Complication
Coronary artery disease
coronavirus disease
COVID-19
COVID-19 disease
described
diagnosed
Dyspnea
ECG
elevated
Elevation
healthy
inflammatory markers
Lake
magnetic resonance imaging
men
Moderna
mRNA-based
mRNA-based COVID-19 vaccine
myocarditis
Other
Patient
Pericarditis
Pfizer-BioNTech
receiving
reduced
reported
second dose
Stress
Stress cardiomyopathy
substernal
Symptoms
the vaccine
Vaccine
ventricular
[DOI] 10.7759/cureus.15576 PMC 바로가기 [Article Type] Cardiology
[DOI] 10.7759/cureus.15576 PMC 바로가기 [Article Type] Cardiology
A Delayed Case of Pericarditis Following Recovery From COVID-19 Infection
Cardiology
[키워드] Atypical
Case report
Chest
Corona Virus Disease
coronavirus
cough
Course
covid pericarditis
COVID-19
Delayed
differential diagnosis
early diagnosis
facilitate
Fever
Infection
initial
male
management
myalgias
patients with COVID-19
pericardial diseases
pericardial effusion
Pericarditis
positive COVID-19
positive PCR
Symptoms
ultrasound (u/s)
worsening
[DOI] 10.7759/cureus.14397 PMC 바로가기 [Article Type] Cardiology
[DOI] 10.7759/cureus.14397 PMC 바로가기 [Article Type] Cardiology
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
COVID-19 폐렴 환자에서 호흡 악화 예방을 위한 BIO101의 효능 및 안전성 테스트(COVA 연구): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
20-hydroxyecdysone
absence
accumulation
ACE2
Activation
acute respiratory distress
acute respiratory distress syndrome
adaptive
addition
administration
Airway Pressure
all-cause mortality
ALT
Alter
amenorrhea
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin converting enzyme-2
Anti-inflammatory
anticipated
approved
ARDS
arterial oxygen saturation
AST
Asymptomatic
balance
baseline
being
Belgium
beneficiary
Bilirubin
BIO101
Biomarker
Biomarkers
birth control
blinded
Brazil
breath
Cardiomyopathy
Care
Caregivers
caused
clinical development
Clinical finding
Clinical findings
clinical picture
co-morbidities
co-morbidity
collected
Compliance
condition
condom
conducted
confirmation
Consumption
Continuous
Continuous Positive Airway Pressure
Contraception
contraceptive method
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infection symptom
COVID-19 infection symptoms
COVID-19 patient
COVID-19 patients
criteria
criterion
daily dose
Day
death
defined
Department
Deterioration
develop
diabetes
diagnosis of COVID-19
dialysis
discharge
discharged
disease
dissemination
DMC
dose
double-blind
downstream
ECMO
Effect
effective
Efficacy
Efficacy and safety
EGFR
element
eligible participant
Eligible participants
endotracheal tube
Endpoint
enzyme
etonogestrel
EudraCT
European
evaluate
event
Evidence
evidence of
exclusion criteria
expected
exploratory
extracorporeal membrane oxygenation
female
female participants
Final
FiO2
Flow
following
form
France
French
functional
Gault
Gender
healthcare
healthcare facility
heart disease
High-flow oxygen
higher risk
hospital
hospital care
Hospitalization
Hospitalized
hypersensitivity
hypertension
IBM
ICF
Imbalance
include
Inclusion
independent
indication
Infection
Inflammation
informed consent form
injection
Interim analyses
interim analysis
Intervention
intrauterine device
Intubated
Invasive mechanical ventilation
IWRS system
lactating
limit
Liver function
liver function tests
male participants
marker
Mas receptor
maximum
measure
mechanical ventilation
medical intervention
medication
medications
minute
moderate
morbidities
Moribund
Mortality
mouth
Multiorgan dysfunction
muscles
myocarditis
negative urine pregnancy test
Non-COVID-19
number
obesity
objective
observation
offer
Older
oral contraceptive
outcome
outlined
oxygen
Part
participant
partner
pathway
Pathways
patients with COVID-19
patients with SARS-CoV-2
PCR
performed
Pericarditis
Physical examination
Placebo
placebo-controlled
Pneumonia
positive airway pressure
post-intervention
post-menopausal
powder
pregnancy test
pressure
primary endpoint
proof
proportion
Proportion of participant
protocol
public health
randomised
randomised controlled trial
randomization
RAS
reached
receive
receiving
receptor
recruited
recruitment
Registered
renal
renal disease
renal insufficiency
Renin
renin angiotensin system
renin-angiotensin system
reproduction
required
resource
respiratory
Respiratory distress syndrome
Respiratory failure
Respiratory function
respiratory symptoms
restored
risk
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 spike protein
second
secondary
secondary endpoint
security
severe pneumonia
Shock
Social Security
specimen
Sperm
Spike protein
SpO2
Statistical power
status
Sterilization
Stratification
stratified
study medication
Study protocol
supplementary material
survival
suspicion
Symptom
syndrome
tachypnea
target population
tested
Testing
the primary endpoint
therapeutic
therapeutic option
tissue
Tolerability
Total
total bilirubin
Treatment
treatment arm
treatment period
Triage
Trial
Trial registration
ULN
Urine
USA
variety
vasectomy
Version
Viral load
water
website
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
A Rare Case of Acute Pericarditis Due to SARS-CoV-2 Managed With Aspirin and Colchicine
Cardiology
[키워드] Acute pericarditis
Arthritis
Aspirin
Chest
Colchicine
cough
COVID 19
COVID-19 pneumonia
debatable
Ejection fraction
elevated
FIVE
High dose
hypertension
Infection
Injury
myocarditis
Nasopharyngeal swab
nonsteroidal anti-inflammatory drug
NSAIDS
oxygen saturation
Patient
patients with SARS-CoV-2
Pericarditis
positive
predominant
reported
rising
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 RNA
Shortness of breath
treated
ventricular
viral pericarditis
[DOI] 10.7759/cureus.12534 PMC 바로가기 [Article Type] Cardiology
[DOI] 10.7759/cureus.12534 PMC 바로가기 [Article Type] Cardiology